about
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infectionVitamin D, the immune system and asthmaDepigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3.Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes.Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patientsVitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways diseaseA comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infectionDistinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: Potential benefits of calcitriolRegulatory T cells in asthma.Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.1α,25-dihydroxyvitamin D3 acts via transforming growth factor-β to up-regulate expression of immunosuppressive CD73 on human CD4+ Foxp3- T cellsRelationship between serum vitamin D, disease severity, and airway remodeling in children with asthma.1α,25-dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells.The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cellsRegulatory T cells and IL-10 in allergic inflammation.In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.T regulatory cells and the control of allergic disease.Regulatory T cells in human disease and their potential for therapeutic manipulation.Interleukin-10-secreting regulatory T cells in allergy and asthma.Urban Particulate Matter-Activated Human Dendritic Cells Induce the Expansion of Potent Inflammatory Th1, Th2, and Th17 Effector Cells.Regulatory T cell therapy as individualized medicine for asthma and allergy.Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.Strategies for use of IL-10 or its antagonists in human disease.Regulatory T cells in bronchial asthma.Regulatory T cells, inflammation and the allergic response-The role of glucocorticoids and Vitamin D.The impact of vitamin D on regulatory T cells.Vitamin D and asthma in children.Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma.Developments in the field of allergy in 2013 through the eyes of Clinical and Experimental Allergy.Vitamin D influences asthmatic pathology through its action on diverse immunological pathways.Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial.Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.Vitamin D Counteracts an IL-23-Dependent IL-17A+IFN-γ+ Response Driven by Urban Particulate Matter.ASTHMA - comparing the impact of vitamin D versus UVR on clinical and immune parameters.Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomalleiDouble-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs).Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment.
P50
Q28299361-69A30677-0032-45EB-9A79-3766ECD6082AQ33616343-3677A3D4-F6FA-423A-A901-B7EE8F3653E8Q33732171-9D6215A6-BDD0-42E8-BDDA-6B5D4E9DEE3EQ33821390-031740B7-E984-4458-B46A-E900DB3BA55EQ33869850-3B3D11C1-A91E-4056-8453-42DAF44942B5Q34065797-E9177C74-0235-4550-B761-61C464F0C274Q34195964-94F9EE08-B9FB-4D20-9533-775FBACC58C5Q35086209-FF7BCB84-0748-493C-8FC9-C85B02F8B6C3Q35892921-6DB3F7E4-FF99-41E3-BA64-9E58ADAD2B8AQ36024285-B073FBAC-0BE5-46F4-8735-BE92A52D77BBQ36064548-7E1FD85B-9D10-4A3C-BAA8-1B66C3FD0BFAQ36073821-D5DE2C15-5EF9-4CE0-B00F-9BB42D50D299Q36176421-6447A499-77C2-43A0-832A-84772810EC03Q36316785-E98CA6FC-0BF8-42F5-A04C-AB4FE4E72612Q36316790-A93DE410-E7C0-49F0-BCC8-C53CB70D8548Q36316807-3A9E8FBB-BD40-4A9D-B95C-F0A4A3C227A0Q36332180-A1DBEA33-D3E7-4ED0-A26C-AE9CCBCEBC75Q36370315-478CA5C3-FE87-4611-BAE2-70D4457512D3Q36377204-3A4D11DD-F00E-4F9B-9027-84BB68BCE904Q36455974-FBFFE6E2-7AF4-4DAC-A7D0-B7B2CE378170Q36561222-B2E212C8-2A56-479C-9581-83D0C0B57989Q36765939-8458236A-D02E-4FCB-8346-C1E95062E423Q36995973-D8057817-3AD4-44C3-9478-4CED9046AD9EQ37073695-2F5F4F1C-B420-43DF-9AAD-56B144EEB657Q37211255-284E4451-3F46-49C7-8226-8BD9A57AB244Q37394142-31CEE477-EF17-41F6-96F2-F4EB5B1A79FFQ37708757-F59E7111-25C3-4ED1-A054-344F92E3B796Q37811986-FF1AB383-86C9-4037-8E61-E42056637CD3Q38052273-3D926C82-3687-45A2-B882-9633F05C4118Q38205046-6880E01E-B1E8-4E63-802F-396114E84900Q38262867-B6667283-BB9F-46A9-AC61-30C09C99BCFEQ38294551-A196744E-F8BC-4781-9EAF-6A814415C9A3Q38396698-EB0477A8-FB7B-4C53-8867-1105DA173730Q38688803-B345E3C9-635C-4A31-8FD9-D4209DA717A6Q38809435-87E49726-F3C2-42A9-86FD-224004A0B2EFQ39090564-7B0623E3-94C3-4605-8515-DDB7545385DAQ39129977-2E248455-6036-46FA-9C7F-5B0A89FC6B71Q39219248-BF838CA4-21EC-4218-966C-EC9231CE66EDQ39219255-96D18365-E196-40F2-9717-7BD5BBC9D340Q39368352-803BB351-596C-41B5-B4D8-992AF2D40ED1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Catherine M Hawrylowicz
@nl
Catherine M Hawrylowicz
@sl
Catherine M. Hawrylowicz
@en
Catherine M. Hawrylowicz
@es
type
label
Catherine M Hawrylowicz
@nl
Catherine M Hawrylowicz
@sl
Catherine M. Hawrylowicz
@en
Catherine M. Hawrylowicz
@es
prefLabel
Catherine M Hawrylowicz
@nl
Catherine M Hawrylowicz
@sl
Catherine M. Hawrylowicz
@en
Catherine M. Hawrylowicz
@es
P1053
Q-8483-2017
P106
P1153
7004126309
P21
P31
P3829
P3835
catherine-hawrylowicz
P496
0000-0002-2337-7463